Sigma Planning Corp Sells 8,955 Shares of Ventas, Inc. $VTR

Sigma Planning Corp lessened its holdings in Ventas, Inc. (NYSE:VTR) by 34.5% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 17,015 shares of the real estate investment trust’s stock after selling 8,955 shares during the quarter. Sigma Planning Corp’s holdings in Ventas were worth $1,317,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in VTR. Vanguard Group Inc. grew its position in Ventas by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock worth $5,876,856,000 after buying an additional 2,349,176 shares in the last quarter. UBS Group AG boosted its position in shares of Ventas by 142.4% during the 3rd quarter. UBS Group AG now owns 3,507,841 shares of the real estate investment trust’s stock valued at $245,514,000 after acquiring an additional 2,060,770 shares during the last quarter. Lasalle Investment Management Securities LLC grew its holdings in shares of Ventas by 1,135.1% during the third quarter. Lasalle Investment Management Securities LLC now owns 1,552,880 shares of the real estate investment trust’s stock worth $108,686,000 after purchasing an additional 1,427,151 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Ventas by 74.2% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,586,405 shares of the real estate investment trust’s stock worth $181,022,000 after purchasing an additional 1,101,948 shares in the last quarter. Finally, Invesco Ltd. increased its position in shares of Ventas by 21.5% in the third quarter. Invesco Ltd. now owns 5,847,604 shares of the real estate investment trust’s stock worth $409,274,000 after purchasing an additional 1,034,634 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Ventas Price Performance

Shares of Ventas stock opened at $88.11 on Monday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. Ventas, Inc. has a 52-week low of $61.76 and a 52-week high of $88.41. The company has a fifty day moving average of $84.79 and a 200-day moving average of $80.20. The stock has a market capitalization of $42.83 billion, a price-to-earnings ratio of 160.20, a price-to-earnings-growth ratio of 2.17 and a beta of 0.74.

Ventas (NYSE:VTR) last issued its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the previous year, the business earned $0.84 EPS. Ventas’s revenue for the quarter was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Equities research analysts expect that Ventas, Inc. will post 3.85 EPS for the current year.

Ventas Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st were paid a $0.52 dividend. This is a boost from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. Ventas’s dividend payout ratio is presently 378.18%.

Insiders Place Their Bets

In related news, EVP Carey S. Roberts sold 35,532 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the transaction, the executive vice president directly owned 72,755 shares in the company, valued at $6,184,175. This trade represents a 32.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.53% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

VTR has been the subject of several research analyst reports. Citigroup lifted their target price on shares of Ventas from $96.00 to $100.00 and gave the company a “buy” rating in a research report on Friday. Evercore restated an “outperform” rating and set a $95.00 price objective on shares of Ventas in a research report on Wednesday. Royal Bank Of Canada lifted their price objective on shares of Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a report on Tuesday, February 10th. Morgan Stanley set a $90.00 target price on shares of Ventas in a research report on Friday, February 13th. Finally, UBS Group reissued a “neutral” rating and issued a $85.00 target price on shares of Ventas in a research note on Monday, February 9th. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Ventas has a consensus rating of “Moderate Buy” and a consensus target price of $91.73.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.